| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Jun 24 | KYMR Kymera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 31.2 | 16,000 | 499.20 k | 16,000 |
| 17 Jun 24 | ADCT ADC Therapeutics | Common Shares | Sell | Dispose S | No | No | 2.89 | 6,995 | 20.22 k | 80,886 |
| 14 Jun 24 | PRLD Prelude Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 3.9 | 23,500 | 91.65 k | 23,500 |
| 13 Jun 24 | ADCT ADC Therapeutics | Common Shares | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 87,881 |
| 7 May 24 | MRUS Merus | Share Option Common Shares | Grant | Acquire A | No | No | 48.73 | 8,844 | 430.97 k | 8,844 |
